Drug intelligence / Profile preview

thiolutin

Development stage
Discontinued
Lead developer
Streptomyces
Modality
Small Molecules
Administration
Not Intended For Human Use (laboratory Reagent Only)
01

Overview

**Thiolutin** is a dithiolopyrrolone and sulfur-containing antibiotic synthesized by various *Streptomyces* species, notably *Streptomyces luteosporeus*[1][10]. It displays broad-spectrum antibacterial and some antifungal activity, along with notable anti-angiogenic effects[1][3][10]. Thiolutin acts as a potent, reversible inhibitor of bacterial and yeast DNA-dependent RNA polymerases (types I, II, and III), thereby blocking RNA synthesis (transcription)[1][3][5][9][10]. It is also reported to inhibit certain JAMM domain zinc metalloproteases (e.g., Rpn11, Csn5, AMSH, Brcc36)[2][7], act as a zinc chelator, and disrupt cellular processes like mRNA degradation and cytoskeletal organization (via Hsp27 perturbation), which leads to the inhibition of endothelial cell adhesion and angiogenesis[1][2][3][6][7]. Thiolutin is primarily used as a research tool, including in the study of mRNA synthesis and stability, not as a human therapeutic agent[4][6][9]. Its effects are reversible, making it valued in experimental modulation of transcription[5].

Other names
acetopyrrothinacetopyrrothinepropiopyvothinefarcinicin
02

Targets

RNAP (Bacterial dna-dependent RNA polymerase)HSPB1 (Heat shock protein beta-1)DUB (Deubiquitinases)

Beyond the preview

Go deeper on thiolutin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiolutin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call